1. The Current and Future Treatment of Brain Metastases
   Douglas A. Hardesty et al, 2016, Frontiers in Surgery CrossRef
2. Systemic treatment of brain metastases in non-small cell lung cancer
   Simon Page et al, 2020, European Journal of Cancer CrossRef
3. Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients
   DIRK RADES et al, 2015, Oncology Letters CrossRef
4. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells
   Yuri Lee et al, 2022, Cancers CrossRef
5. Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity
   D Zhang et al, 2017, Oncogene CrossRef
6. Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis
   Rute M. S. M. Pedrosa et al, 2018, Frontiers in Oncology CrossRef
7. Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes
   Tomas Tokar et al, 2018, Oncotarget CrossRef
8. Advances in decoding breast cancer brain metastasis
   Chenyu Zhang et al, 2016, Cancer and Metastasis Reviews CrossRef
9. Value of Oncogenes for the Prediction of Brain Metastases at Initial Diagnosis: A Review of Published Data
   Qian Huang et al, 2014, The International Journal of Biological Markers CrossRef
10. Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response
    Romi Biswas et al, 2016, Molecular Case Studies CrossRef
11. Innovations in Metastatic Brain Tumor Treatment
    Caleb Stewart et al, 2020, Brain and Spinal Tumors - Primary and Secondary CrossRef
12. Estimation of the Survival of Patients With Lung Squamous Cell Carcinoma Using Genomic Copy Number Aberrations
    Yan Cao et al, 2016, Clinical Lung Cancer CrossRef
13. Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value
    Yvonne Chekaluk et al, 2013, PLoS ONE CrossRef
14. Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma
    Yinqiang Liu et al, 2023, Cancer Management and Research CrossRef
15. Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma
    Hye Won Lee et al, 2013, Clinical Cancer Research CrossRef
16. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non‐small cell lung cancer (NSCLC) cells
    Benedikt Müller et al, 2015, The Journal of Pathology CrossRef
17. Acquirement of DNA copy number variations in non-small cell lung cancer metastasis to the brain
    FANG LI et al, 2015, Oncology Reports CrossRef
18. Actin Alpha 2, Smooth Muscle (ACTA2) Is Involved in the Migratory Potential of Malignant Gliomas, and Its Increased Expression at Recurrence Is a Significant Adverse Prognostic Factor
    Takumi Hoshimaru et al, 2023, Brain Sciences CrossRef